Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 15, 2026

Procter & Gamble (PG) Stock After Recent Pullback Is The Current Price Tag Justified

View original at finance.yahoo.com
Procter & Gamble (PG) Stock After Recent Pullback Is The Current Price Tag Justified Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The estimated intrinsic value of Procter & Gamble is approximately $186.75 per share based on discounted cash flow modeling

    60% confidence
  • Procter & Gamble scores 3 out of 6 on Simply Wall St's 6-point valuation checklist

    60% confidence
  • Procter & Gamble's free cash flow is projected to reach approximately $21.3 billion by 2035 under the DCF model's assumptions

    60% confidence
  • Procter & Gamble is a large consumer staples stock that many investors watch closely when reassessing defensive holdings and income-focused positions

    60% confidence
  • The DCF model output implies Procter & Gamble stock is 19.9% undervalued relative to its current share price of approximately $149.61

    60% confidence
  • The DCF model uses analyst-provided free cash flow estimates for the next few years, then extrapolates beyond that horizon

    60% confidence

Data points we hold from this source

Procter & Gamble · stock price149.61 USD
Procter & Gamble · margin2.1 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Procter & Gamble (PG) Stock After Recent Pullback Is The Current Price Tag Justified — Source | Via News | ViaNews Market